These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 31017293)

  • 1. [De novo sporadic mutation in the KCND3 gene in a patient with early onset chronic ataxia].
    Carrasco-Marina ML; Quijada-Fraile P; Fernandez-Marmiesse A; Gutierrez-Cruz N; Martin-Del Valle F
    Rev Neurol; 2019 May; 68(9):398-399. PubMed ID: 31017293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First de novo KCND3 mutation causes severe Kv4.3 channel dysfunction leading to early onset cerebellar ataxia, intellectual disability, oral apraxia and epilepsy.
    Smets K; Duarri A; Deconinck T; Ceulemans B; van de Warrenburg BP; Züchner S; Gonzalez MA; Schüle R; Synofzik M; Van der Aa N; De Jonghe P; Verbeek DS; Baets J
    BMC Med Genet; 2015 Jul; 16():51. PubMed ID: 26189493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene mutational analysis in a cohort of Chinese children with unexplained epilepsy: Identification of a new KCND3 phenotype and novel genes causing Dravet syndrome.
    Wang J; Wen Y; Zhang Q; Yu S; Chen Y; Wu X; Zhang Y; Bao X
    Seizure; 2019 Mar; 66():26-30. PubMed ID: 30776697
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Pollini L; Galosi S; Tolve M; Caputi C; Carducci C; Angeloni A; Leuzzi V
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823520
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel KCND3 gain-of-function mutation associated with early-onset of persistent lone atrial fibrillation.
    Olesen MS; Refsgaard L; Holst AG; Larsen AP; Grubb S; Haunsø S; Svendsen JH; Olesen SP; Schmitt N; Calloe K
    Cardiovasc Res; 2013 Jun; 98(3):488-95. PubMed ID: 23400760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The L450F [Corrected] mutation in KCND3 brings spinocerebellar ataxia and Brugada syndrome closer together.
    Duarri A; Nibbeling E; Fokkens MR; Meijer M; Boddeke E; Lagrange E; Stevanin G; Brice A; Durr A; Verbeek DS
    Neurogenetics; 2013 Nov; 14(3-4):257-8. PubMed ID: 23963749
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel Features and Abnormal Pattern of Cerebral Glucose Metabolism in Spinocerebellar Ataxia 19.
    Paucar M; Bergendal Å; Gustavsson P; Nordenskjöld M; Laffita-Mesa J; Savitcheva I; Svenningsson P
    Cerebellum; 2018 Aug; 17(4):465-476. PubMed ID: 29527639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19.
    Duarri A; Jezierska J; Fokkens M; Meijer M; Schelhaas HJ; den Dunnen WF; van Dijk F; Verschuuren-Bemelmans C; Hageman G; van de Vlies P; Küsters B; van de Warrenburg BP; Kremer B; Wijmenga C; Sinke RJ; Swertz MA; Kampinga HH; Boddeke E; Verbeek DS
    Ann Neurol; 2012 Dec; 72(6):870-80. PubMed ID: 23280838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Cardiocerebral Channelopathy Associated with a KCND3 V392I Mutation.
    Nakajima T; Kawabata-Iwakawa R; Kaneko Y; Hamano SI; Sano R; Tamura S; Hasegawa H; Kobari T; Kominato Y; Nishiyama M; Kurabayashi M
    Int Heart J; 2020 Sep; 61(5):1049-1055. PubMed ID: 32921676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KCND3 mutations in Brugada syndrome: the plot thickens.
    van den Berg MP; Bezzina CR
    Heart Rhythm; 2011 Jul; 8(7):1033-5. PubMed ID: 21640846
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel SCA19/22-associated KCND3 mutations disrupt human K
    Hsiao CT; Fu SJ; Liu YT; Lu YH; Zhong CY; Tang CY; Soong BW; Jeng CJ
    Hum Mutat; 2019 Nov; 40(11):2088-2107. PubMed ID: 31293010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VARPRISM: incorporating variant prioritization in tests of de novo mutation association.
    Hu H; Coon H; Li M; Yandell M; Huff CD
    Genome Med; 2016 Aug; 8(1):91. PubMed ID: 27562213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kv4.2 autism and epilepsy mutation enhances inactivation of closed channels but impairs access to inactivated state after opening.
    Lin MA; Cannon SC; Papazian DM
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3559-E3568. PubMed ID: 29581270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repolarization matters: mutations in the Kv4.3 potassium channel cause SCA19/22.
    Pulst SM; Otis TS
    Ann Neurol; 2012 Dec; 72(6):829-31. PubMed ID: 23280833
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic background of apparently idiopathic sporadic cerebellar ataxia.
    Schöls L; Szymanski S; Peters S; Przuntek H; Epplen JT; Hardt C; Riess O
    Hum Genet; 2000 Aug; 107(2):132-7. PubMed ID: 11030410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mutation in the KCNJ10 gene in three siblings with seizures, ataxia and no electrolyte abnormalities.
    Al Dhaibani MA; El-Hattab AW; Holroyd KB; Orthmann-Murphy J; Larson VA; Siddiqui KA; Szolics M; Schiess N
    J Neurogenet; 2018 Mar; 32(1):1-5. PubMed ID: 29191078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo mutation in CACNA1A caused acetazolamide-responsive episodic ataxia.
    Yue Q; Jen JC; Thwe MM; Nelson SF; Baloh RW
    Am J Med Genet; 1998 May; 77(4):298-301. PubMed ID: 9600739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy.
    Corbett MA; Bellows ST; Li M; Carroll R; Micallef S; Carvill GL; Myers CT; Howell KB; Maljevic S; Lerche H; Gazina EV; Mefford HC; Bahlo M; Berkovic SF; Petrou S; Scheffer IE; Gecz J
    Neurology; 2016 Nov; 87(19):1975-1984. PubMed ID: 27733563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ataxia and myoclonic epilepsy due to a heterozygous new mutation in KCNA2: proposal for a new channelopathy.
    Pena SD; Coimbra RL
    Clin Genet; 2015 Feb; 87(2):e1-3. PubMed ID: 25477152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital ataxia and hemiplegic migraine with cerebral edema associated with a novel gain of function mutation in the calcium channel CACNA1A.
    García Segarra N; Gautschi I; Mittaz-Crettol L; Kallay Zetchi C; Al-Qusairi L; Van Bemmelen MX; Maeder P; Bonafé L; Schild L; Roulet-Perez E
    J Neurol Sci; 2014 Jul; 342(1-2):69-78. PubMed ID: 24836863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.